Methylglyoxal (MG) 抗体
Quick Overview for Methylglyoxal (MG) 抗体 (ABIN335418)
抗原
适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
特异性
- Specific for MG-modified protein (especially Argpyrimidine).
-
纯化方法
- Protein A purified
-
免疫原
- MG modified keyhole-limpet hemocyanin.
-
亚型
- IgG2a
-
-
anti-Methylglyoxal (MG) antibody
ELISA, WB, ICC, FACS, IF, IHC 宿主: 小鼠 Monoclonal 9E7 unconjugated
anti-Methylglyoxal (MG) antibody (HRP)ELISA, WB, ICC, FACS, IF, IHC 宿主: 小鼠 Monoclonal 9E7 HRP
anti-Methylglyoxal (MG) antibody (FITC)ELISA, WB, ICC, FACS, IF, IHC 宿主: 小鼠 Monoclonal 9E7 FITC
anti-Methylglyoxal (MG) antibody (Biotin)ELISA, WB, ICC, FACS, IF, IHC 宿主: 小鼠 Monoclonal 9E7 Biotin
anti-Methylglyoxal (MG) antibody (PE)ELISA, WB, ICC, FACS, IF, IHC 宿主: 小鼠 Monoclonal 9E7 PE
anti-Methylglyoxal (MG) antibody (PerCP)ELISA, WB, ICC, FACS, IF, IHC 宿主: 小鼠 Monoclonal 9E7 PerCP
anti-Methylglyoxal (MG) antibody (APC)ELISA, WB, ICC, FACS, IF, IHC 宿主: 小鼠 Monoclonal 9E7 APC
anti-Methylglyoxal (MG) antibody (Atto 488)ELISA, WB, ICC, FACS, IF, IHC 宿主: 小鼠 Monoclonal 9E7 Atto 488
anti-Methylglyoxal (MG) antibody (Atto 594)ELISA, WB, ICC, FACS, IF, IHC 宿主: 小鼠 Monoclonal 9E7 Atto 594
anti-Methylglyoxal (MG) antibody (Atto 390)ELISA, WB, ICC, FACS, IF, IHC 宿主: 小鼠 Monoclonal 9E7 Atto 390
-
-
应用备注
- IHC: 0.5-1.0 ug/mL on paraformaldehyde fixed tissue. User should determine optimum titer for each application.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- Liquid: 100 ug IgG/mL in 10 mM PBS containing 0.1 %NaN 3 and 0.5 % BSA. Protein A purified.
-
储存液
- Sodium azide
-
注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
-
- Methylglyoxal (MG)
-
物质类
- Chemical
-
背景
- Methylglyoxal (MG), an endogenous metabolite that increases in diabetes and is a common intermediate in the Maillard glycation reaction. MG reacts with proteins and forms advanced glycation end products (AGEs). MG reacts with residues in proteins and forms numerous adducts,such as argpyrimidine.
抗原
-
